SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Filament Health Signs PEX010 Supply Agreement With Linköping University

Rhelion Life Sciences says its subsidiary Filament Health signed an agreement to supply PEX010 for a social anxiety disorder trial at Linköping University.

RHEL

Story updates

12:08:01 PM UTC
SquawkNews
Rhelion said subsidiary Filament Health signed a supply and licensing agreement to provide PEX010 to Linköping University for the PsiloSAD clinical trial evaluating psilocybin for social anxiety disorder. Linköping is the sponsor; Filament is not responsible for trial conduct.Material DetailsContex…

Related stories